UPMC Enterprises, the medical technology investment arm of UPMC, has purchased interest in RxAnte, a company that uses analytics to predict how patients will adhere to the medications they’re prescribed.
Read more on Pittsburgh Business Times.
Pittsburgh Business Times: UPMC Enterprises invests in prescription analytics company RxAnte
Related Resources
More Resources12.02.20
How does medication use impact 2021 Star Ratings?
Blog Post
Using our interactive tool, you can see the correlation between Star Ratings and medication adherence firsthand. Curious about how you stack up against similar plans? Set the measure-specific performance sliders to your plans’ Star Ratings to see how you compare.
11.10.20
RxAnte Clients Outperform Industry Peers on 2021 Star Ratings Performance amid Increasing Performance Thresholds
Press Release
The Centers for Medicare and Medicaid Services (CMS) released its 2021 Star Ratings (covering calendar year 2019) in early October, and performance data show that Medicare Advantage health plans partnering with analytics and clinical services company RxAnte continue to outpace industry performance.
10.19.20
CMS 2021 Star Ratings: What are the industry-level takeaways?
Case Study
This document summarizes various industry trends over time on Part C and D measures using CMS data. Hover over plots for detailed information.